Meridian Bioscience, Inc. (NASDAQ:VIVO)
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
youngbuc25
(94.81)
Submitted: 8/23/2007 7:44:09 PM :
Start Price:
$21.95
VIVO Score:
-7.53
A Pick from my small cap screen.
Recs
uncommonCents
(78.00)
Submitted: 8/15/2007 5:29:16 PM :
Start Price:
$19.43
VIVO Score:
+9.08
Over 10 years of dividend growth is almost unheard of in a small-cap. Would buy more on a pull-back.
Recs
bdbartle1
(96.57)
Submitted: 7/18/2007 1:38:08 PM :
Start Price:
$19.44
VIVO Score:
+8.33
High Dividend Growth
High ROE
High Gross Margin
Zero Debt
S&P Earnings & Dividend Rank: B+ or Higher
S&P Fair Value Rank: 3 or higher
Recs
TrueNate
(41.70)
Submitted: 6/5/2007 3:58:32 AM :
Start Price:
$18.39
VIVO Score:
+13.45
Should have got on this sooner, to capitalize on the share split that happened recently. With the dividends and record earnings, I believe that this one will grow.
Recs
tewilson57
(< 20)
Submitted: 5/23/2007 12:35:10 PM :
Start Price:
$17.76
VIVO Score:
+16.84
Highly-regarded products; solid commitment to ongoing R&D.
Recs
doggetla
(66.46)
Submitted: 5/17/2007 10:45:49 PM :
Start Price:
$17.46
VIVO Score:
+17.99
fast growing dividend paying small-cap - products are use and throw away
Recs
Rockland61
(87.33)
Submitted: 4/27/2007 2:28:28 PM :
Start Price:
$17.23
VIVO Score:
+17.97
Makes the proven goods in the bioscience industry and distributes their products to the world. Good return in the health field without the huge expense of R&D like the drug companies.
Recs
BaaMan
(85.50)
Submitted: 4/10/2007 2:14:30 PM :
Start Price:
$16.47
VIVO Score:
+19.95
Solid company, good growth + Div. Made a bundle the past few years. Look for pop near end of year.
Recs
5SsmallcapDIV
(77.23)
Submitted: 2/26/2007 10:34:24 AM :
Start Price:
$15.66
VIVO Score:
+26.09
5 Star/Small cap/Pays dividend
Recs
fengshuiplatinum
(< 20)
Submitted: 2/14/2007 10:49:24 PM :
Start Price:
$16.32
VIVO Score:
+21.29
med tests for the masses
Recs
RRick1004
(< 20)
Submitted: 2/8/2007 7:45:42 PM :
Start Price:
$16.56
VIVO Score:
+19.19
Like the energizer bunny, VIVO just keeps on going
Recs
dymaxian
(93.12)
Submitted: 1/29/2007 4:03:27 PM :
Start Price:
$16.72
VIVO Score:
+16.21
Good health-care play. As more money comes into the health care sector, more will come the way of companies like Meridian who provide the gear doctors need to do their work. Whether the hospitals and clinics are well-managed and successful or not, they'll need to buy the equipment. This isn't far from my favorite old adage: whether the gold miners strike gold or not, the people selling shovels will make out like bandits.
Recs
jtinman43
(< 20)
Submitted: 11/17/2006 8:04:30 PM :
Start Price:
$14.15
VIVO Score:
+35.49
East to use medical test will continue to grow
Recs
jbopdycke
(< 20)
Submitted: 11/17/2006 2:24:40 PM :
Start Price:
$14.13
VIVO Score:
+35.38
no pitch. Just a well run company.
Recs
alvinegasber
(48.74)
Submitted: 11/8/2006 7:03:04 AM :
Start Price:
$13.42
VIVO Score:
+37.08
Time o buy!
Recs
RandyWill
(89.40)
Submitted: 10/22/2006 2:02:47 PM :
Start Price:
$12.99
VIVO Score:
+45.01
One of five stocks I am adding to force myself to keep an eye on them...turned up through screening...have not fully researched.
Recs
jefecabra
(51.26)
Submitted: 9/21/2006 5:00:07 PM :
Start Price:
$13.89
VIVO Score:
+32.50
Great dividend paying small cap medical diagnostic company going into the flu season.
Recs
mlmcgarv
(24.58)
Submitted: 8/29/2006 8:04:17 PM :
Start Price:
$12.77
VIVO Score:
+41.56
This stock has continued to do two things consistently for the past three years since I bought it: outperfom the market and reward its shareholders. I feel it will continue to do so, over the next 5 years, as I see little downside in the company.
Recs
wwhogan
(54.25)
Submitted: 8/23/2006 2:27:33 PM :
Start Price:
$12.92
VIVO Score:
+40.31
Company should continue to grow, stock has done well over the last 12 months and should continue
Recs
edp9923
(22.52)
Submitted: 8/18/2006 9:29:28 PM :
Start Price:
$13.30
VIVO Score:
+35.96
Recent upgrade by Hilliard Lyons to Long Term Buy. Is partnering with Merck to develop and market new products.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 60 of 62 : « Previous 1 2 3 4 Next »